Gene: COPG2
Official Full Name: COPI coat complex subunit gamma 2provided by HGNC
Gene Summary: Predicted to enable structural molecule activity. Involved in intra-Golgi vesicle-mediated transport. Part of COPI vesicle coat. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27957 | COPG2 Knockout cell line (HeLa) | Human | COPG2 | 1:3~1:6 | Negative | Online Inquiry |
KO27958 | COPG2 Knockout cell line (HCT 116) | Human | COPG2 | 1:2~1:4 | Negative | Online Inquiry |
KO27959 | COPG2 Knockout cell line (HEK293) | Human | COPG2 | 1:3~1:6 | Negative | Online Inquiry |
KO27960 | COPG2 Knockout cell line (A549) | Human | COPG2 | 1:3~1:4 | Negative | Online Inquiry |
COPG2 Gene Knockout Cell Lines represent a groundbreaking tool in genetic research, specifically designed to elucidate the functions of the COPG2 gene, which plays a critical role in cellular processes such as protein transport and Golgi apparatus functionality. These genetically engineered cell lines have been meticulously developed using CRISPR-Cas9 technology to disrupt the COPG2 gene, allowing researchers to study its biological implications in a controlled environment.
The primary function of the COPG2 gene relates to the mediation of vesicular transport, essential for maintaining proper cellular homeostasis and signaling pathways. The knockout of this gene results in a range of phenotypic changes, including alterations in intracellular trafficking and protein mislocalization, thus providing insights into diseases where COPG2 is implicated, such as certain neurodegenerative disorders and cancers. The cell lines facilitate the investigation of compensatory mechanisms and downstream effects, offering a comprehensive view of the gene’s role within cellular dynamics.
This product holds significant scientific importance, particularly in the fields of molecular biology, pharmacology, and cancer research, where understanding gene function is crucial for developing targeted therapeutics. COPG2 Gene Knockout Cell Lines are invaluable for screening drug candidates, studying gene interactions, and validating potential biomarkers, thereby directly contributing to advancing personalized medicine.
One of the standout advantages offered by these cell lines is their compatibility with a variety of assay systems, including high-throughput screening and live-cell imaging. This adaptability allows for significant flexibility in experimental design, making them an efficient choice compared to traditional knockout methods, which can be labor-intensive and time-consuming. Furthermore, the precise CRISPR-Cas9 mediated knockouts reduce the likelihood of off-target effects, leading to more reliable and reproducible results.
For researchers and clinicians looking to deepen their understanding of gene function and its implications in disease, COPG2 Gene Knockout Cell Lines provide a powerful solution that enhances experimental accuracy and relevance. These products are essential for any laboratory focused on cutting-edge genetic studies.
Our company is committed to advancing scientific discovery by offering high-quality, reliable biological products. With expertise in genetic engineering and a focus on customer support, we ensure that researchers have access to the tools they need to push the boundaries of knowledge in the biological sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.